Trials (Georges-François Leclerc Cancer Center): Revision history

14 December 2025

• curprev 20:1620:16, 14 December 2025‎ Francine talk contribs‎ 93,750 bytes +189‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 93,561 bytes +1,701‎ Update categories. undo

3 December 2025

• curprev 12:1112:11, 3 December 2025‎ Francine talk contribs‎ 91,860 bytes +48‎ No edit summary undo

2 December 2025

• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 91,812 bytes +90‎ Update categories. undo

3 December 2023

• curprev 23:5923:59, 3 December 2023‎ Francine talk contribs‎ 91,722 bytes +91,722‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Georges-François Leclerc Cancer Center page '''NCTID''': NCT02947685 '''Title''': Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer '''Study Summary''': The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2-based therapy plus endocrin..."